We are pleased to share that Fabiola Terzi’s team, Mechanisms and Therapeutic Strategies of Chronic Kidney Disease, has been awarded the prestigious FRM team label, a mark of scientific excellence from the Fondation pour la Recherche Médicale.

This recognition will support their research on chronic kidney disease (CKD), a condition that affects approximately 10% of the global adult population and may lead to end-stage renal failure requiring dialysis or transplantation.

The project aims to better understand the biological mechanisms driving CKD progression, with a particular focus on the HIPPO signaling pathway and its effectors YAP and TAZ, which are involved in cell growth and mechanical stress responses.

With the FRM support, this research will contribute to a deeper understanding of CKD and pave the way for innovative therapeutic strategies for chronic kidney disease.